Trials / Completed
CompletedNCT01592058
Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 427 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to learn whether women who use progestin-only methods of birth control such as the contraceptive implant (Implanon), the levonorgestral-releasing IUS (Mirena), or depot medroxyprogesterone acetate(DMPA) will experience weight change compared to women using the non-hormonal copper IUC (ParaGard). The investigators primary hypothesis is that users of DMPA will gain excess weight and increase their BMI above the copper-IUC users; secondarily, the investigators will compare users' data in the LNG-IUC and ENG implant groups to the copper-IUC group.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2012-05-04
- Last updated
- 2012-07-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01592058. Inclusion in this directory is not an endorsement.